B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Sb590885

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Sb590885, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

avutometinib
2 shared targets
naporafenib
2 shared targets
ly
2 shared targets
gw305074x
2 shared targets
regorafenib
2 shared targets
cep
2 shared targets
Vemurafenib
2 shared targets · score 43.2
pi
2 shared targets
motesanib
2 shared targets
sb
2 shared targets
Loading evidence profile...

This evidence profile for Sb590885 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.